MindWave Innovations Inc. USA, a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), has entered into a two-year master maintenance and service agreement with BlockAssure Inc. to build, deploy, and operate AssureChain, a dedicated subnet of MindChain designed specifically for BlockAssure's insurance and reinsurance operations. The agreement, which took effect on October 4, 2026, positions MindWave as BlockAssure's exclusive blockchain provider for AssureChain during the term.
Under the agreement, MindWave will design, develop, security-audit, and deploy AssureChain, and will subsequently host, operate, and maintain the network. AssureChain is intended to support a range of insurance-related functions, including contracts, policies, premium and payment entries, reinsurance treaties, and claims processing. MindChain will serve as the settlement layer and anchor AssureChain records to Ethereum, providing a transparent and secure infrastructure.
In return, MindWave will receive contracted development fees payable in quarterly installments, with operating and maintenance fees to be agreed upon later. Additionally, MindWave will receive an allocation equal to 20% of the total supply of AssureCoin, a planned digital token within the MindChain network. The development is planned over four quarters, and the agreement will automatically renew for one-year periods after the initial two-year term unless either party provides 90 days' notice.
This deal marks a significant step for MindWave as it expands its technology into the insurance and reinsurance sectors. By leveraging blockchain, AssureChain aims to bring greater transparency, traceability, and efficiency to insurance processes, potentially reducing costs and improving trust among parties. For Apimeds Pharmaceuticals, this venture could open new revenue streams and demonstrate the versatility of its blockchain infrastructure. Investors can find more details in the full press release available at https://ccw.fm/bVeq4.
The broader implications for the insurance industry could be substantial. Blockchain technology has the potential to streamline claims processing, reduce fraud, and enable more efficient reinsurance transactions. If successful, AssureChain could serve as a model for other insurers looking to adopt distributed ledger technology. MindWave's parent company, Apimeds Pharmaceuticals US, Inc., is listed on the NYSE American under the ticker APUS, and the latest news and updates are available in the company's newsroom at Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS).
CryptoCurrencyWire, a specialized communications platform focused on blockchain and cryptocurrency, originally distributed the announcement. The platform is part of the Dynamic Brand Portfolio at IBN, which provides wire solutions through InvestorWire, editorial syndication to 5,000+ outlets, and social media distribution. As blockchain adoption grows in traditional industries, this partnership highlights the increasing convergence of digital assets and mainstream finance.
